A live grey market premium quote for Molbio Diagnostics IPO has not been reported yet. Check back closer to the price band announcement and subscription window for updated GMP figures.
Molbio Diagnostics GMP Today
Track live unofficial grey market premium, expected listing price, historical session trends, and lot-wise profit estimates for Molbio Diagnostics IPO.
Latest GMP
Pending
Quote Pending
Est. Listing Price
TBA
Cap ₹807 + GMP
Est. Gain / Lot
TBA
Lot size TBA
IPO Price Band
₹807
TBA
Molbio Diagnostics Day-wise GMP Trend
Chronological grey market premium quotes, expected listing prices, and percentage changes.
No historical GMP sessions recorded yet for Molbio Diagnostics
Day-wise grey market entries appear automatically once unofficial quotes start trading prior to the bidding window.
Molbio Diagnostics GMP Profit & Lot Calculator
Estimate potential listing-day profit across Retail and HNI lot quantities using current or custom GMP values.
Price band and minimum lot size for Molbio Diagnostics IPO have not been finalized yet. You can still model custom IPO listing scenarios in our standalone calculator.
Open IPO CalculatorHow Molbio Diagnostics Estimated Listing Price Is Calculated
The estimated listing price combines the upper end of the IPO price band with the latest unofficial grey market premium. Multiply the GMP per share by the lot size to estimate the indicative listing gain for one allotment lot.
Estimated Listing Price Formula
Upper Price Band + Latest GMP
Indicative Gain per Retail Lot
Latest GMP × Retail Lot Size
Molbio Diagnostics IPO Key Dates & Issue Facts
- Issue Opens
- —
- Issue Closes
- —
- Basis of Allotment
- —
- Tentative Listing
- —
- Issue Size
- —
- Face Value
- —
- Min. Lot Investment
- —
- Registrar
- —
Molbio Diagnostics GMP Frequently Asked Questions
The estimated listing price is calculated by adding the latest GMP to the upper end of the Molbio Diagnostics IPO price band (₹807). Once both the price band and an active GMP quote are available, the estimated listing price updates automatically.
The lot size for Molbio Diagnostics IPO will be confirmed in the RHP. Expected profit per lot is estimated by multiplying the current GMP by the number of shares in one lot.
Bidding dates: TBA.
No. Molbio Diagnostics IPO GMP is an unofficial, unregulated sentiment indicator observed in the grey market and is not published by SEBI, NSE, BSE, or the company. Always evaluate the RHP, financial statements, valuation, and risk factors before applying.